Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains

The Ca2+-dependent cysteine proteases, calpains, regulate cell migration, cell death, insulin secretion, synaptic function and muscle homeostasis. Their endogenous inhibitor, calpastatin, consists of four inhibitory repeats, each of which neutralizes an activated calpain with exquisite specificity and potency. Despite the physiological importance of this interaction, the structural basis of calpain inhibition by calpastatin is unknown. Here we report the 3.0 Å structure of Ca2+-bound m-calpain in complex with the first calpastatin repeat, both from rat, revealing the mechanism of exclusive specificity. The structure highlights the complexity of calpain activation by Ca2+, illustrating key residues in a peripheral domain that serve to stabilize the protease core on Ca2+ binding. Fully activated calpain binds ten Ca2+ atoms, resulting in several conformational changes allowing recognition by calpastatin. Calpain inhibition is mediated by the intimate contact with three critical regions of calpastatin. Two regions target the penta-EF-hand domains of calpain and the third occupies the substrate-binding cleft, projecting a loop around the active site thiol to evade proteolysis.

[1]  Z. Jia,et al.  A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.

[2]  J. Beckmann,et al.  Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). , 2007, Biochimica et biophysica acta.

[3]  Z. Jia,et al.  Crystal structure of a micro-like calpain reveals a partially activated conformation with low Ca2+ requirement. , 2003, Structure.

[4]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[5]  D. McRee,et al.  A visual protein crystallographic software system for X11/Xview , 1992 .

[6]  Z. Jia,et al.  Ca(2+)-induced structural changes in rat m-calpain revealed by partial proteolysis. , 2001, Biochimica et biophysica acta.

[7]  H. Sambrook Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[8]  M. Cygler,et al.  Roles of individual EF-hands in the activation of m-calpain by calcium. , 2000, The Biochemical journal.

[9]  Ming Liu,et al.  Calpain in the CNS: From Synaptic Function to Neurotoxicity , 2008, Science Signaling.

[10]  Sarah Dennison,et al.  Calpains and Their Multiple Roles in Diabetes Mellitus , 2006, Annals of the New York Academy of Sciences.

[11]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[12]  M. Cygler,et al.  Structure of a calpain Ca2+-binding domain reveals a novel EF-hand and Ca2+-induced conformational changes , 1997, Nature Structural Biology.

[13]  H. Sorimachi,et al.  Structure, activation, and biology of calpain. , 2004, Diabetes.

[14]  F. Mackenzie,et al.  The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition. , 2007, Journal of molecular biology.

[15]  R. Huber,et al.  Structural basis of the endoproteinase-protein inhibitor interaction. , 2000, Biochimica et biophysica acta.

[16]  Z. Jia,et al.  Crystal structure of calpain reveals the structural basis for Ca2+‐dependent protease activity and a novel mode of enzyme activation , 1999, The EMBO journal.

[17]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[18]  Anna Huttenlocher,et al.  Regulating cell migration: calpains make the cut , 2005, Journal of Cell Science.

[19]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[20]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[21]  R. Kiss,et al.  Calcium‐induced tripartite binding of intrinsically disordered calpastatin to its cognate enzyme, calpain , 2008, FEBS letters.

[22]  W. Bode,et al.  Flexibility Analysis and Structure Comparison of Two Crystal Forms of Calcium-Free Human m-Calpain , 2002, Biological chemistry.

[23]  M. Bogyo,et al.  Development of Calpain-specific Inactivators by Screening of Positional Scanning Epoxide Libraries* , 2007, Journal of Biological Chemistry.

[24]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[25]  P. Davies,et al.  Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography. , 1995, Protein engineering.

[26]  Bruce A Johnson,et al.  Using NMRView to visualize and analyze the NMR spectra of macromolecules. , 2004, Methods in molecular biology.

[27]  D. E. Goll,et al.  Interaction of calpastatin with calpain: a review , 2004, Biological chemistry.

[28]  F. Morón,et al.  The therapeutic potential of the calpain family: new aspects. , 2006, Drug discovery today.

[29]  J. Beckmann,et al.  Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. , 2001, Biophysical journal.

[30]  R. Campbell,et al.  Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site. , 2004, Journal of molecular biology.

[31]  Z. Jia,et al.  Calpain silencing by a reversible intrinsic mechanism , 2003, Nature Structural Biology.

[32]  R. Campbell,et al.  Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.

[33]  J. Anagli,et al.  Structural Determinants of the Calpain Inhibitory Activity of Calpastatin Peptide B27-WT* , 2003, The Journal of Biological Chemistry.

[34]  G N Murshudov,et al.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[35]  G. Lin,et al.  A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. , 2003, Journal of molecular biology.

[36]  L. DeLucas,et al.  Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding , 1997, Nature Structural Biology.

[37]  P. Davies,et al.  Determination of peptide substrate specificity for mu-calpain by a peptide library-based approach: the importance of primed side interactions. , 2005, The Journal of biological chemistry.

[38]  R. Huber,et al.  The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.